Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. (2023)

First Author: Donovan K
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2215/cjn.05080422

PubMed Identifier: 36719157

Publication URI: http://europepmc.org/abstract/MED/36719157

Type: Journal Article/Review

Volume: 18

Parent Publication: Clinical journal of the American Society of Nephrology : CJASN

Issue: 1

ISSN: 1555-9041